PCM
ASTH icon

Penserra Capital Management’s Astrana Health ASTH Stock Holding History

Penserra Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Buy
+63,424
New +$2.28M 0.02% 321

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Penserra Capital Management's ASTH Position: Q2 2026 in Review

Penserra Capital Management opened a new position in Astrana Health (ASTH) in Q2 2026: 63,424 shares worth $2.94M. The stake represents 0.02% of the portfolio and ranks #321 among its holdings.

209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Penserra Capital Management held 63,424 shares of Astrana Health worth $2.94M as of Q2 2026.
  • Astrana Health was a new Penserra Capital Management position in Q2 2026.
  • Astrana Health made up 0.02% of Penserra Capital Management's portfolio in Q2 2026, its #321 holding.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.